Literature DB >> 7141711

Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant.

H Okuyama, S Kobayashi, M Fujita, R Yasumizu, K Morikawa.   

Abstract

Localizations of complement component 3 (C3) receptor (C3R)-bearing cells in lymph nodes obtained from normal guinea pigs or from guinea pigs inoculated with complete Freund adjuvant were examined by staining with fluorescein-labeled anti-guinea pig C3 antibody after treatment with aggregated rabbit immunoglobulin M bound with guinea pig complement. In normal lymph nodes, a small number of C3R-positive cells were observed in the cortical and medullary areas. Non-granulomatous lymph nodes from complete Freund adjuvant-inoculated animals showed a number of C3R-positive lymphocytes in a mantle zone of the secondary follicles between the follicles and medullary cords, whereas in the paracortical areas and germinal centers, only a few positive cells were scattered. Long-lasting existence of positive cells was seen in the epithelioid cell granuloma, although the staining patterns were different from those of the lymphocytes. The appearance of a number of C3R-bearing lymphocytes in lymph nodes from complete Freund adjuvant-inoculated animals might be an expression of adjuvant activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141711      PMCID: PMC347798          DOI: 10.1128/iai.38.2.724-730.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Receptors for complement and immunoglobulin on human and animal lymphoid cells.

Authors:  E M Shevach; E S Jaffe; I Green
Journal:  Transplant Rev       Date:  1973

2.  L2C Guinea pig lymphatic leukemia: a "B" cell leukemia.

Authors:  E M Shevach; L Ellman; J M Davie; I Green
Journal:  Blood       Date:  1972-01       Impact factor: 22.113

Review 3.  Receptors for immune complexes on lymphocytes.

Authors:  V Nussenzweig
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

4.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Bone marrow-derived lymphoid cells (B cells): functional depletion with cobra factor and fresh serum.

Authors:  N L Levy; D W Scott; R Snyderman
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

6.  Binding of thymus- and bone marrow-derived lymphoid cells to antigen-derivatized fibers.

Authors:  U Rutishauser; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

7.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

8.  Tissue localization of two populations of human lymphocytes distinguished by membrane receptors.

Authors:  N P Silveira; N F Mendes; M E Tolnai
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

9.  Complement-dependent B-cell activation by cobra venom factor and other mitogens?

Authors:  P Dukor; G Schumann; R H Gisler; M Dierich; W König; U Hadding; D Bitter-Suermann
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes.

Authors:  K J Gajl-Peczalska; A J Fish; H J Meuwissen; D Frommel; R A Good
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

View more
  1 in total

1.  In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model.

Authors:  Amélie Démosthènes; Benoît Sion; Fabrice Giraudet; Xavier Moisset; Laurence Daulhac; Alain Eschalier; Mélina Bégou
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.